• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺苷酸激酶:人类前列腺癌动物模型中的一种肿瘤发生发展标志物。

Adenylate kinase: an oncodevelopmental marker in an animal model for human prostatic cancer.

作者信息

Hall M, Mickey D D, Wenger A S, Silverman L M

出版信息

Clin Chem. 1985 Oct;31(10):1689-91.

PMID:2994906
Abstract

Data are presented demonstrating that adenylate kinase (AK; EC 2.7.4.3) is an oncodevelopmental enzyme in the prostate of Copenhagen rats. We selected the Dunning tumor (dorsal rat prostate) as a model system because it most nearly approximates the human pathology. Four sublines of the tumor (R3327-H, R3327-AT, MAT Lu, and MAT LyLu) were studied. The tumor sublines were maintained as solid tumors in syngeneic rats and as monolayers in tissue culture. AK activity appeared in conjunction with malignant transformation of the dorsal prostate. We also determined the normal developmental enzyme pattern: AK was present in prostates of newborns, but was undetectable in prostates of adults. However, AK increased after castration. Therefore, we propose AK as a potential oncofetal tumor marker in prostatic cancer.

摘要

数据表明,腺苷酸激酶(AK;EC 2.7.4.3)是哥本哈根大鼠前列腺中的一种肿瘤发生发展相关酶。我们选择邓宁肿瘤(大鼠背侧前列腺)作为模型系统,因为它最接近人类病理学情况。对该肿瘤的四个亚系(R3327 - H、R3327 - AT、MAT Lu和MAT LyLu)进行了研究。肿瘤亚系在同基因大鼠中作为实体瘤维持,并在组织培养中作为单层细胞维持。AK活性与背侧前列腺的恶性转化同时出现。我们还确定了正常发育过程中的酶模式:AK存在于新生儿前列腺中,但在成年前列腺中无法检测到。然而,去势后AK增加。因此,我们提出AK作为前列腺癌潜在的癌胚肿瘤标志物。

相似文献

1
Adenylate kinase: an oncodevelopmental marker in an animal model for human prostatic cancer.腺苷酸激酶:人类前列腺癌动物模型中的一种肿瘤发生发展标志物。
Clin Chem. 1985 Oct;31(10):1689-91.
2
Oncodevelopmental enzymes of the Dunning rat prostatic adenocarcinoma.邓宁大鼠前列腺腺癌的胚胎发育相关酶
Cancer Res. 1985 Sep;45(9):4053-9.
3
Overexpression of protein kinase C-zeta (PKC-zeta) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells.蛋白激酶C-ζ(PKC-ζ)的过表达抑制了邓宁R-3327 MAT-LyLu大鼠前列腺癌细胞的侵袭和转移能力。
Cancer Res. 1996 Sep 15;56(18):4137-41.
4
Differential expression of protein kinase C isozyme messenger RNAs in dunning R-3327 rat prostatic tumors.蛋白激酶C同工酶信使核糖核酸在邓宁R-3327大鼠前列腺肿瘤中的差异表达
Cell Growth Differ. 1994 Feb;5(2):143-9.
5
In vitro characterization of MAT LyLu: a Dunning rat prostate adenocarcinoma tumor subline.
J Urol. 1984 Jun;131(6):1232-6. doi: 10.1016/s0022-5347(17)50879-4.
6
Growth-related elevations of DNA topoisomerase II levels found in Dunning R3327 rat prostatic adenocarcinomas.在邓宁R3327大鼠前列腺腺癌中发现与生长相关的DNA拓扑异构酶II水平升高。
Cancer Res. 1987 Jun 15;47(12):3246-50.
7
Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin.口服改性柑橘果胶对大鼠前列腺癌模型自发转移的抑制作用。
J Natl Cancer Inst. 1995 Mar 1;87(5):348-53. doi: 10.1093/jnci/87.5.348.
8
Expression of ras proto-oncogenes in the Dunning R3327 rat prostatic adenocarcinoma system.
Prostate. 1988;13(4):273-87. doi: 10.1002/pros.2990130403.
9
Immunoregulatory markers in rats carrying Dunning R3327 H, G, or MAT-LyLu prostatic adenocarcinoma variants.携带邓宁R3327 H、G或MAT-LyLu前列腺腺癌变体的大鼠中的免疫调节标志物。
Cancer Res. 1987 Jan 1;47(1):178-82.
10
Acid phosphatase-producing androgen-independent subline of rat prostatic adenocarcinoma (Dunning R3327 tumor) in cell culture.细胞培养中大鼠前列腺腺癌(邓宁R3327肿瘤)产生酸性磷酸酶的雄激素非依赖性亚系。
Prostate. 1984;5(1):113-22. doi: 10.1002/pros.2990050111.

引用本文的文献

1
Simple oxygraphic analysis for the presence of adenylate kinase 1 and 2 in normal and tumor cells.用于分析正常细胞和肿瘤细胞中腺苷酸激酶1和2存在情况的简易氧电极分析方法。
J Bioenerg Biomembr. 2016 Oct;48(5):531-548. doi: 10.1007/s10863-016-9687-3. Epub 2016 Nov 17.
2
Metabolomic profiling of lung and prostate tumor tissues by capillary electrophoresis time-of-flight mass spectrometry.采用毛细管电泳飞行时间质谱法对肺和前列腺肿瘤组织进行代谢组学分析。
Metabolomics. 2013 Apr;9(2):444-453. doi: 10.1007/s11306-012-0452-2. Epub 2012 Nov 2.